Peer-reviewedCC BYFrontiers in pharmacology
Bioactive compounds from Perilla frutescens modulate multiple cell death pathways and signaling networks in cancer therapy
6 affiliations
- 1Huangjiahu Hospital, Hubei University of Chinese Medicine , ,
- 2First Clinical College, Hubei University of Chinese Medicine , ,
- 3Department of Medical Biotechnology, College of Biotechnology, Misr University for Science and Technology , ,
- 4College of Life Science, Hubei University , ,
- 5Oncology Department, Hubei Provincial Hospital of Traditional Chinese Medicine , ,
- 6Key Laboratory of Biology and Genetic Improvement of Oil Crops, Ministry of Agriculture and Rural Affairs, Oil Crops Research Institute, Chinese Academy of Agricultural Sciences , ,
Related
- In Silico Exploration of Foods and Compounds That Modulate Nicotine Metabolism
- Editorial: Impact of plant bioactive compounds on human nutrition and health
- Integrated counter current separation and omics approaches for discovery of bioactive compounds from medicinal plants
- Potential role of resveratrol in abdominal cocoon syndrome: targeting inflammation, oxidative stress, and fibrosis via food-derived bioactive compounds resveratrol for treatment of abdominal cocoon syndrome
- Bioactive compounds and antioxidant activity of Arbutus fruits from the black sea region
BibTeX
@article{xu2026bioactive,
title = {{Bioactive compounds from Perilla frutescens modulate multiple cell death pathways and signaling networks in cancer therapy}},
author = {Hai Xu and Jingyi Liu and Huikun Wu and Hussein Sabit and Bangquan Huang and Yong Zhou and Lei Wang and Linhai Wang},
journal = {Frontiers in pharmacology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13655542},
note = {CC BY},
}
RIS
TY - JOUR
TI - Bioactive compounds from Perilla frutescens modulate multiple cell death pathways and signaling networks in cancer therapy
AU - Hai Xu
AU - Jingyi Liu
AU - Huikun Wu
AU - Hussein Sabit
AU - Bangquan Huang
AU - Yong Zhou
AU - Lei Wang
AU - Linhai Wang
PY - 2026
DA - 2026/10/16
JO - Frontiers in pharmacology
UR - https://europepmc.org/article/PMC/PMC13655542
SN - 1663-9812
ER -